The role of mitochondria in sepsis-induced cardiomyopathy.


Journal

Biochimica et biophysica acta. Molecular basis of disease
ISSN: 1879-260X
Titre abrégé: Biochim Biophys Acta Mol Basis Dis
Pays: Netherlands
ID NLM: 101731730

Informations de publication

Date de publication:
01 04 2019
Historique:
received: 23 08 2018
revised: 02 10 2018
accepted: 05 10 2018
pubmed: 21 10 2018
medline: 30 11 2019
entrez: 21 10 2018
Statut: ppublish

Résumé

Sepsis is defined as a life-threatening organ dysfunction caused by a dysregulated host response to infection. Myocardial dysfunction, often termed sepsis-induced cardiomyopathy, is a frequent complication and is associated with worse outcomes. Numerous mechanisms contribute to sepsis-induced cardiomyopathy and a growing body of evidence suggests that bioenergetic and metabolic derangements play a central role in its development; however, there are significant discrepancies in the literature, perhaps reflecting variability in the experimental models employed or in the host response to sepsis. The condition is characterised by lack of significant cell death, normal tissue oxygen levels and, in survivors, reversibility of organ dysfunction. The functional changes observed in cardiac tissue may represent an adaptive response to prolonged stress that limits cell death, improving the potential for recovery. In this review, we describe our current understanding of the pathophysiology underlying myocardial dysfunction in sepsis, with a focus on disrupted mitochondrial processes.

Identifiants

pubmed: 30342158
pii: S0925-4439(18)30388-0
doi: 10.1016/j.bbadis.2018.10.011
pii:
doi:

Types de publication

Journal Article Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

759-773

Subventions

Organisme : Medical Research Council
ID : MR/N013867/1
Pays : United Kingdom

Informations de copyright

Copyright © 2018 Elsevier B.V. All rights reserved.

Auteurs

Giacomo Stanzani (G)

Bloomsbury Institute of Intensive Care Medicine, Division of Medicine, University College London, Cruciform Building, Gower St, WC1E 6BT London, UK.

Michael R Duchen (MR)

UCL Consortium for Mitochondrial Research, Department of Cell and Developmental Biology, University College London, Medical Sciences Building, Gower St, WC1E 6BT London, UK.

Mervyn Singer (M)

Bloomsbury Institute of Intensive Care Medicine, Division of Medicine, University College London, Cruciform Building, Gower St, WC1E 6BT London, UK. Electronic address: m.singer@ucl.ac.uk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH